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To explore the role ofDDE, the major and most persistent DDT derivative, in cancer etiology,
weexaminedthe association ofthe 1968 adipose DDE levels ofpopulation samples from 22 U.S.
states with age-adjusted mortality rates between 1975 and 1994 for multiple mycloma; non-
Hodgkin lymphoma (NHL); and cancer ofthe breast, corpus uteri, liver, and pancreas. Separate
analyses wereconducted bygenderand race. Covariates in the ression models induded average
per-capita income, percent metropolitan residents, and the population density. Liver cancer mor-
talityincreased significantlywithadipose DDElevels in both sexes amongwhites, but not among
African Americans. No association was observed for pancreatic cancer and multiple myeloma.
Breast cancer mortalitywas inverselycorrelated with adipose DDE levels amrong both white and
African American women. Significant inverse correlations were also observed for uterine cancer
among white women, whereas no association was observed for AfricanAmericans and for NHL
amongwhites (men andwomen) andAfricanAmericanwomen. Theresults forpancreatic cancer,
multiple myeloma, NHL, breast cancer,and uterine cancer did not support the hypothesis ofan
association with past adipose levels ofthe DDT derivative DDE. The multivariate analysis con-
firmed most findings. The association between liver cancer and DDE observed among whites,
particularly in view of the occurrence ofhepatic neoplasms in laboratory animals exposed to
DDT, warrants fiurther investigation. Key word breast cancer, cancer ofthe corpus uteri, DDE,
DDT, environment, epidemiology, liver cancer, multiple myeloma, non-Hodgkin lymphoma,
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Agricultural use of the insecticide DDT was
banned in 1973 in the United States and in
most Western countries. However, some
Eastern European countries and numerous
developing countries still use DDT, primarily
in the prevention of malaria, typhus, yellow
fever, and sleeping sickness (1). The current
industrial production ofDDT is only a small
fraction of the 80,000 tons produced in
1963. However, concern exists over possible
health consequences of its indiscriminate use
in the past because of its prolonged half-life
and biologic persistence, which may extend
over several decades, particularly in temperate
climates (1). The ability ofthe prevalent iso-
mer of the major and most persistent DDT
derivative, p,p'-dichlorodiphenyldichloro-
ethylene (p,p'-DDE), to bind to the andro-
gen receptor in male rats has been reported
(2). In 1991, the International Agency for
Research on Cancer evaluated the evidence of
DDT carcinogenicity as sufficient in experi-
mental animals (1). Subcutaneous injection
and oral administration of DDT and its
metabolites such as DDE and dichlorodi-
phenyldichloroethane were followed by a
dose-related increase of liver tumors in mice
and rats. Results were less consistent for
malignant lymphomas, lung carcinomas, and
thyroid tumors (1). Concern has been
cxpressed about the possible link between
environmental exposure to organochlorines
and an increase in incidence of various can-
cers among humans (3).
Epidemiologic data on cancer risk associ-
ated with exposure to DDT are suggestive,
but limitations in the exposure assessment
and the finding of small and inconsistent
excesses complicate the interpretation.
Elevated risks of non-Hodgkin lymphoma
(NHL) in relation to potential exposure to
DDT has been found in Washington State
(4) and in Sweden (5). A slight increase of
leukemia occurred among Iowa farmers that
used DDT and had other agricultural expo-
sures (6). A case-control study on pancreatic
cancer found a strong dose-related association
with exposure to DDT (7) although its posi-
tive results have not been replicated thus far.
Breast cancer risk has also been repeatedly
associated with increased adipose and serum
levels of DDE in the general population
(8-11), although more recent studies yield
contradictory or negative results (12-16). The
p,p'-DDE concentration was elevated in the
tumor tissue ofpatients suffering from uterine
cancer as compared to the surrounding nor-
mal tissue (17), although the risk ofendome-
trial cancer was not increased in relation to
serum pp'-DDE concentrations (18). A pre-
liminary study of the mortality experience of
DDT applicators in Sardinia, Italy, found an
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increase in mortality from liver cancer and
multiple myeloma (19).
To explore the hypothesis of a link
between mortality from six cancer sites,
namely liver, pancreas, breast, corpus uteri,
multiple myeloma, and NHL, and exposure
to the DDT derivative DDE in the United
States, we examined the correlation between
cancer mortality rates and the past DDE
concentration in the subcutaneous adipose
tissue of population samples from 22 states
in the United States.
Methods
Data on DDE concentrations in the subcu-
taneous fat ofpopulation samples of22 U.S.
states (Alabama, Arkansas, California,
Connecticut, Delaware, Georgia, Illinois,
Indiana, Louisiana, Massachusetts, Missouri,
Nevada, New Mexico, New York, North
Carolina, Ohio, Pennsylvania, South
Dakota, Tennessee, Texas, Washington, and
Wisconsin) were obtained from a U.S.
Environmental Protection Agency (EPA)
human monitoring program report of 1968
data (20). The report provided data on aver-
age level of DDE (micrograms per gram)
and sample size by state and race. Based on
the estimated half-life of organochlorines in
the human body (7 years for DDT, several
decades for DDE) (21), and on latency con-
siderations in human cancerogenesis, we
compared state-specific adipose DDE levels
in 1968 to standardized mortality rates
in 1975-1994.
Age-adjusted mortality rates from cancers
ofthe liver, pancreas, breast, and corpus uteri;
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multiple myeloma; and NHL in 1975-1994,
overall and every 5 years, specific by U.S. state
and by race, were provided by the National
Center for Health Statistics in computerized
form. The 1970 U.S. population was the stan-
dard. Multiple linear regression analysis was
conducted with SPSS (SPSS, Inc., Chicago,
IL), usingthe REGRESSION feature.
Information on possible confounders of
the association between DDE environmental
contamination and mortality from the six
cancers was available from public resources
(22). We selected average per capita income,
percent of state population living in metro-
politan areas, population density, birth rate,
and abortion rate per 1,000 live births. The
two last variables were used to construct a
pregnancy rate. Only three covariates (per
capita income, metropolitan residence, and
population density) were correlated with one
or more cancer sites and they were included
in the multiple linear regression models. No
adipose DDE measurements were available
in three states for African Americans; there-
fore, analyses for African Americans were
restricted to 19 states. These analyses were
conducted using a weighted regression pro-
cedure, with the size ofthe population sam-
ple surveyed by the U.S. EPA in each state in
1968 as theweight.
The statistical significance of the regres-
sion coefficients (p) was calculated from the
ratio ofP and its standard error, which has a
t distribution under the null hypothesis.
Two-tailed tests were used to assess statistical
significance.
Results
Adipose DDE levels showed a strong positive
correlation (r = 0.746; p = 0.0002) between
whites and African Americans, indicating
that interstate variations were in the same
direction in both race groups (Figure 1). In
addition, such high correlation provides par-
tial reassurance for our decision to use those
measurements as indicators ofenvironmental
contamination from DDT across U.S. states.
Adipose DDE levels were 74% higher among
o
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Figure 1. Correlation between adipose p,p'-
dichlorodiphenyidichloroethylene levels among
whites and African Americans in 19 U.S. states
(20). R= 0.746, p < 0.001.
African Americans as compared to whites
over the 19 U.S. states with measurements
available for both race groups (African
Americans 8.49 ,ug/g ± 4.16; whites 4.88
,ug/g ± 1.87; t= 6.69;p < 0.001) (Figure 2).
Table 1 shows the correlation matrix of
socioeconomic variables and adipose DDE
with mortality from each cancer site in the
four study groups. Annual income and met-
ropolitan residence showed a significant cor-
relation with liver cancer mortality among
African Americans and with pancreatic can-
cer mortality among white women. Annual
income, metropolitan residence, and popula-
tion densitywere significantly correlated with
breast cancer mortality among white women,
whereas only metropolitan residence showed
a significant association among African
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American women. Pregnancy rate was not
related to breast cancer mortality in either
race group. None ofthe socioeconomic vari-
ables were correlated with mortality from
uterine cancer. Population density was associ-
ated with NHL mortality among men, but
not among women. Metropolitan residence
was inversely related with multiple myeloma
among African American men and white
women. A weak positive correlation was also
observed with population density among
white men.
In the univariate analysis (Table 1), liver
cancer mortality increased with increasing
levels ofadipose DDE amongwhite men and
women, but not among African Americans.
Mortality from pancreatic cancer and multi-
ple myeloma did not vary according to DDE
State
Figure 2. Adipose DDE levels in population samples of 22 U.S. states (20).
Table 1. Mortality from six cancers associated with socioeconomic factors and
states: correlation coefficients from univariate analysis.
Canccer
site Study group
Liver White men
African American men
White women
African American women
Pancreas White men
African American men
White women
African American women
Breast White women
African American women
Corpus White women
uteri African American women
Multiple White men
myeloma African American men
White women
African American women
Non- White men
Hodgkin African American men
lymphoma White women
African American women
Annual
income
0.193
0.439**
-0.197
0.377*
-0.082
-0.272
0.457**
-0.080
0.573**
0.299
0.022
0.115
0.097
0.330
0.293
0.213
-0.037
0.273
0.137
0.053
Metropolitan
residence
0.263
0.547**
0.245
0.525**
0.107
-0.183
0.361*
-0.100
0.539**
0.565*
0.183
0.129
0.199
-0.448*
-0.329
-0.018
0.240
0.114
0.118
-0.293
Population
density
0.190
0.162
0.066
0.229
0.063
-0.001
0.083
-0.070
0.553**
0.258
0.143
0.242
0.311
-0.117
0.149
-0.080
0.394*
0.301
0.013
0.068
adipose DDE in 22 U.S.
Pregnancy Adipose
rate DDE
- 0.416*
- -0.378
- 0.413*
- -0.250
- 0.041
_ --0.199
_ -0.126
- -0.118
0.112 -0.731**
0.142 -0.501*
0.064 -0.632**
0.221 0.023
- 0.205
- 0.026
- -0.123
- 0.053
- -0.471*
- -0.218
- -0.507*
- -0.497*
*p < 0.05. **p < 0.01.
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levels in any ofthe study groups. Breast can-
cer mortality among women showed a signif-
icant inverse correlation with DDE levels
among either race group. Mortality from
cancer of the corpus uteri was also inversely
correlated with adipose DDE levels, but only
among whites. An inverse correlation was
also observed with NHL mortality in three of
the four study groups.
The multivariate analysis (Table 2) con-
firmed the increase in liver cancer mortality
with increasing adipose DDE levels among
whites, which was significant only among
men, whereas no association was observed
among African Americans. None of the
other cancer sites under investigation
showed a positive association with DDE lev-
els. Cancer of the breast and corpus uteri
were both inversely affected by DDE levels,
and the regression coefficients were highly
significant among white women. NHL mor-
tality also decreased with increasing DDE
levels, but only among whites. With regard
to socioeconomic covariates in the regression
models, metropolitan residence was signifi-
cantly associated with NHL mortality and
liver cancer mortality, respectively, in three
and two of four study groups. The associa-
tion was still positive, although nonsignifi-
cant, in the remaining study groups for
either cancer site. Breast cancer mortality
was also positively associated with metropol-
itan residence, but only among white
women. In the multivariate models, state
population density did not affect cancer
mortality rates, perhaps because of the
adjustment for metropolitan residence.
Average annual income was inversely associ-
ated with liver cancer mortality in three of
four study groups, but the regression coeffi-
cient was significant only among white
women. We also explored the same associa-
tions by 5-year periods from 1975 onward.
The results confirmed our observation using
mortality rates over the entire study period.
Discussion
Our exploratory epidemiologic exercise
showed no evidence ofa consistently signifi-
cant increase in mortality with increasing
adipose DDE levels measured in 1968. A
positive association was observed for liver
cancer, but only among whites. Mortality
from breast cancer, uterine cancer, and NHL
was inversely related to DDE levels in one or
more study groups. Remarkably, the associa-
tion between adipose DDE and liver cancer
mortality was not significant in the first
decade, but it became statistically significant
from 1985 onward among white women
and in 1990-1994 amongwhite men.
Ecologicanalysis-such as the one report-
ed here-is onlya preliminary step in the epi-
demiologic inquiry of human health effects
after exposure to environmental contami-
nants. The advantages oflow cost and quick
execution are counterbalanced by the poten-
tial for bias, resulting from assumptions that
the whole population of a given geographic
area shares the same level ofexposure to envi-
ronmental contaminants, a problem referred
to as the "ecological fallacy" (23). Race and
low social dass are important determinants of
geographic variability in environmental expo-
sure and riskofdisease (24). Indeed, based on
the EPA human monitoring data, African
Americans had adipose DDE levels 74%
higher than whites on average. We used state
average annual income in the multivariate
model to account for this confounding effect.
Another weakness of this analysis is that we
used mortality rather than incidence rates.
Results for cancers with better survival rates,
such as breast cancer and NHL, could have
been moreseverelyaffected.
An association between exposure to DDT
and liver cancer was suggested by experimen-
tal studies (1) and a recent proportional mor-
tality study (19). Our results are only partially
consistent with these reports because ofdiffer-
ences in race. Earlier reports ofan increase in
breast cancer risk associated with increasing
adipose and serum DDE levels (8-11) were
not supported by other recent studies show-
ing no association (13-16). Our results are
consistent with these latter reports. The risk
of endometrial cancer was not increased in
relation to serum p,p'-DDE levels (18),
whereas levels of DDT and its derivatives
were higher in the leiomyomatous tissue as
compared to the surrounding normal uterine
tissue (17). Cancers arising from the
endometrium and from the muscular walls of
the corpus uteri are jointly considered in the
International Classification ofDiseases, 9th
revision (World Health Organization,
Geneva) coding of the causes of death on
which the death statistics were based. In our
analysis, mortality from cancer of the corpus
uteri was not associated with adipose DDE
levels. A pooled analysis ofthree case-control
studies ofNHL among U.S. male farmers did
not show consistent evidence for an associa-
tion with exposure to DDT (25). In our
study, we found a negative association, ifany.
We did not find evidence ofa positive associ-
ation with pancreatic cancer and multiple
myeloma, in contrast to previous epidemio-
logic and pathologic reports (7,19). Although
our study may provide partial reassurance on
the magnitude of cancer risk associated with
environmental exposure to the DDT deriva-
tive DDE, its limitations and the vast public
Table2. Mortalityfrom six cancers associated with socioeconomic riskfactors and adipose DDE in 22 U.S. states: multivariate analysis.
Cancer site Study group
Liver White men
African American men
White women
African American women
Pancreas White men
African American men
White women
African American women
Breast White women
African American women
Corpus White women
uteri African American women
Multiple White men
myeloma African American men
White women
African American women
Non- White men
Hodgkin African American men
lymphoma White women
African American women
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Annual
income
0.015(0.121)
-0.479(0.294)
-0.147 (0.044)**
-0.203 (0.121)
0.037 (0.135)
0.702(0.468)
0.077 (0.112)
0.213 (0.253)
0.237 (0.502)
-0.633 (1.018)
0.135 (0.099)
0.216 (0.388)
-0.062 (0.053)
0.036 (0.372)
-0.027 (0.032)
0.249 (0.566)
Constant
1.553 (0.978)
7.002(2.584)*
2.043 (0.353)**
2.741 (1.064)*
9.625 (1.093)**
2.562 (4.112)**
5.062 (0.910)**
8.056 (2.228)**
24.294 (3.761 )**
34.656 (7.817)**
1.262 (0.742)
3.171 (2.981)
3.808 (0.398)**
6.846 (2.856)**
2.401 (0.243)**
4.362 (4.349)
6.829 (0.452)**
3.404(0.923)**
4.842 (0.241 )**
2.066 (0.536)**
Metropolitan
residence
0.013 (0.010)
0.065(0.0281*
0.013 (0.004)**
0.027 (0.01l)*
0.001 (0.011)
-0.072(0.044)
0.013(0.009)
-0.003 (0.024)
0.057 (0.030)
0.065(0.063)
-0.001 (0.006)
-0.032 (0.024)
0.002(0.003)
-0.007 (0.023)
0.001 (0.002)
-0.023 (0.035)
0.015(0.0061*
0.018(0.011)
0.006(0.003)**
0.014(0.006)
Population
density
0.001 (0.003)
-0.001 (0.007)
-0.001 (0.001)
0.000 (0.003)
-0.001 (0.001)
-0.001 (0.001)
-0.000 (0.000)
-0.000 (0.001)
Adipose
DDE
0.163 (0.065)*
-0.096 (0.088)
0.034(0.023)
-0.021 (0.036)
0.026 (0.073)
-0.104(0.140)
0.014(0.060)
0.010 (0.076)
-0.947 (0.205)**
-0.401 (0.196)
-0.130 (0.040)*
-0.028 (0.075)
-0.009(0.022)
0.008 (0.072)
-0.010 (0.013)
-0.022 (0.109)
-0.135(0.055)*
0.023 (0.044)
-0.073(0.030)*
-0.018 (0.025)
*p < 0.05.**p < 0.01.
3Articles * Cocco et al.
concern on this matter point toward the need
for more analytic research to confirm or reject
the hypotheses raised by the few positive
reports published to date.
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